Middle East respiratory syndrome (MERS) coronavirus (CoV) causes severe respiratory illness in humans, with death occurring in \>35% of reported cases ([@R1]). MERS has been documented among persons with close contact with known case-patients in healthcare ([@R2]) and household ([@R3]) settings and among persons with recent contact with dromedaries ([@R4]). Proper clinical management of persons with suspected MERS-CoV infection who seek care in a healthcare setting relies upon adherence to recommended infection-control precautions ([@R5]), which in turn depends upon the early recognition of cases.

The International Health Regulations Emergency Committee of the World Health Organization reported that data sharing for this disease, including sharing of surveillance results, "remains limited and has fallen short of expectations" ([@R6]). To determine the extent of MERS surveillance in Saudi Arabia, we reviewed electronic surveillance data collected during April 1, 2015--February 1, 2016, to describe trends in surveillance for MERS and to compare demographic and clinical features among persons tested.

The Study
=========

In Saudi Arabia, persons who should be tested for MERS-CoV include suspect case-patients who meet at least 1 of 4 case definition categories ([Technical Appendix](#SD1){ref-type="local-data"} Table). In brief, the categories are persons with community-acquired pneumonia (category I); healthcare-associated pneumonia (II); symptoms after exposure to a MERS-CoV case-patient (III); or unexplained febrile illness (IV). The case definition was revised in May 2014 ([@R7]); additional refinements were made in June 2015 ([@R8]). The 2015 definition included changes to the approach for testing children [\<]{.ul}14 years of age with nonsevere illness (testing is reserved for children with exposure to camels or camel products or to a confirmed or suspected MERS case-patient). In addition to suspected cases, testing is recommended for close contacts of persons with confirmed MERS-CoV infection, regardless of symptoms, and can also be requested at the discretion of an infectious disease consultant. Tests are performed on respiratory specimens at 5 regional laboratories using real-time PCR ([@R9]).

Since March 7, 2015, official reporting of cases referred for MERS-CoV testing in Saudi Arabia has exclusively been documented through the Health Electronic Surveillance Network (HESN). When a suspected case-patient is identified for testing, the referring hospital reports demographic and basic clinical data to HESN ([Figure 1](#F1){ref-type="fig"}). After specimens are submitted and testing completed, the regional laboratory reports the result to HESN. For positive cases, the referring hospital submits additional clinical information, and the local Health Affairs Directorate (HAD) initiates an investigation of exposures and contacts. For negative test results, no further action is taken in HESN. Surveillance activities occur in each of the 20 local HADs and among Hajj pilgrims. We analyzed demographic, clinical, and laboratory data for persons reported to HESN during April 1, 2015--February 1, 2016, in aggregate and by HAD using Microsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA) and SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA).
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A total of 57,363 suspected MERS case-patients were identified and tested during the study period; 384 (0.7%) tested positive ([Table 1](#T1){ref-type="table"}). Among those for whom nationality and sex were known, 70.3% were Saudi (compared with 67.3% of the general population) and 54.3% were male. Rates of positivity among those with known age differed by age group; highest and lowest rates were among persons 50--65 and [\<]{.ul}14 years of age, respectively ([Table 1](#T1){ref-type="table"}). The month with the highest number of tested persons was November 2015 (n = 9,197) ([Figure 2](#F2){ref-type="fig"}), and the month with the highest percentage of positive tested persons was August 2015 (3.4% of 4,770 tested persons).

###### Demographic characteristics of persons tested for Middle East respiratory syndrome coronavirus, Saudi Arabia, April 1, 2015--February 1, 2016

  Characteristic                                 No. (%) confirmed   No. (%) not confirmed   No. (%) total    \% Positive
  ---------------------------------------------- ------------------- ----------------------- ---------------- -------------
  Overall                                        384                 56,979 (99.3)           57,363 (100.0)   0.7
  Sex                                                                                                         
  F                                              156                 25,863 (45.7)           26,019 (45.7)    0.6
  M                                              226                 30,718 (54.3)           30,944 (54.3)    0.7
  Total                                          382                 56,581                  56,963           0.7
  Nationality                                                                                                 
  Saudi                                          246                 34,628 (70.3)           34,874 (70.3)    0.7
  Non Saudi                                      107                 14,604 (29.7)           14,711 (29.7)    0.7
  Total                                          353                 49,232                  49,585           0.7
  Reason for testing                                                                                          
  Suspected case\*                               286                 47,592 (89.1)           47,878 (89.0)    0.6
  Category I                                     87                  32,284 (60.5)           32,371 (60.2)    0.3
  Category II                                    67                  2,662 (5.0)             2,729 (5.1)      2.5
  Category III                                   107                 4,669 (8.7)             4,776 (8.9)      2.2
  Category IV                                    25                  7,977 (14.9)            8,002 (14.9)     0.3
  Recommended by infectious disease consultant   66                  3,256 (6.1)             3,322 (6.2)      2.0
  Patient asymptomatic                           19                  2,555 (4.8)             2,574 (4.8)      0.7
  Total                                          371                 53,403                  53,774           0.7
  Month of report                                                                                             
  April 2015                                     10                  4,953 (8.7)             4,963 (8.7)      0.2
  May 2015                                       54                  4,414 (7.7)             4,468 (7.8)      1.2
  June 2015                                      24                  3,090 (5.4)             3,114 (5.4)      0.8
  July 2015                                      24                  2,634 (4.6)             2,658 (4.6)      0.9
  August 2015                                    160                 4,610 (8.1)             4,770 (8.3)      3.4
  September 2015                                 66                  6,520 (11.4)            6,586 (11.5)     1.0
  October 2015                                   28                  7,568 (13.3)            7,596 (13.2)     0.4
  November 2015                                  6                   9,191 (16.1)            9,197 (16.0)     0.1
  December 2015                                  5                   7,280 (12.8)            7,285 (12.7)     0.1
  January 2016                                   6                   6,487 (11.4)            6,493 (11.3)     0.1
  February 2016                                  1                   232 (0.4)               233 (0.4)        0.4
  Total                                          384                 56,979                  57,363           0.7
  Age, y                                                                                                      
  0--14                                          10                  8,022 (14.2)            8,032 (14.1)     0.1
  15--34                                         97                  17,621 (31.1)           17,718 (31.1)    0.5
  35--49                                         82                  10,201 (18.0)           10,283 (18.0)    0.8
  50--65                                         109                 10,082 (17.8)           10,191 (17.9)    1.1
  [\>]{.ul}66                                    84                  10,692 (18.9)           10,776 (18.9)    0.8
  Total                                          382                 56,618                  57,000           

\*Categories: I, acute respiratory illness with clinical and/or radiologic evidence of pulmonary parenchymal disease (pneumonia or acute respiratory distress syndrome); II, a hospitalized patient with healthcare associated pneumonia based on clinical and radiological evidence; III, upper or lower respiratory illness within 2 weeks after exposure to a confirmed or probable case of MERS-CoV; IV, unexplained acute febrile ([\>]{.ul}38°C) illness, and body aches, headache, diarrhea, or nausea/vomiting, with or without respiratory symptoms, and leukopenia (white blood cell count \<3.5 × 10^9^/L) and thrombocytopenia (platelets \<150 × 10^9^/L). Descriptions are from the Saudi Arabia Ministry of Health MERS-CoV Case Definition and Surveillance Guidance--Updated June 2015 (<http://www.moh.gov.sa/en/CCC/Regulations/Case%20Definition.pdf>).
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Among tested persons for whom the reason for testing was known, 89.0% met the clinical case definition for suspected MERS ([Table 1](#T1){ref-type="table"}). The remaining 11.0% were those recommended for testing by an infectious disease consultant and asymptomatic contacts of confirmed case-patients. More than half of those tested (60.2%) met the category I definition (community-acquired pneumonia) for a suspected case-patient; 0.3% tested positive. The highest positivity rate, 2.5%, was among persons meeting the category II definition for a suspected case-patient (healthcare-associated pneumonia). Among all persons with presumed exposure to MERS case-patients (persons meeting categories II, III and asymptomatic contacts of confirmed case-patients), the positivity rate was 1.9%. Among the 185 confirmed case-patients with available occupational information, 35 (18.9%) were healthcare workers (data not shown).

Most tested persons were reported in the course of routine surveillance through a local HAD. Nationwide, 18.4 persons/10,000 inhabitants were tested, and 1.2/100,000 were MERS-CoV--positive ([@R10]) ([Table 2](#T2){ref-type="table"}). Rates of testing and positivity varied by HAD; the highest testing rates were in Ahsa HAD, followed by Riyadh HAD. Najran HAD had the highest percentage of positive persons ([Table 2](#T2){ref-type="table"}).

###### Middle East respiratory syndrome cases by local Health Affairs Directorate and among Hajj pilgrims, Saudi Arabia, April 1, 2015--February 1, 2016\*

  Surveillance population            Population   No. positive/no. tested   No. tested/10,000 population   No. confirmed cases/100,000 population   \% Positive
  ---------------------------------- ------------ ------------------------- ------------------------------ ---------------------------------------- -------------
  Local Health Affairs Directorate                                                                                                                  
  Riyadh                             7,717,467    276/22,322                28.9                           3.6                                      1.2
  Jeddah                             4,224,568    10/6,606                  15.6                           0.2                                      0.2
  Eastern                            3,019,461    2/7,319                   24.2                           0.1                                      0
  Makkah                             2,111,127    2/3,729                   17.7                           0.1                                      0.1
  Madinah                            2,012,749    8/2,258                   11.2                           0.4                                      0.4
  Asir                               1,766,212    6/1,730                   9.8                            0.3                                      0.3
  Jazan                              1,533,496    0/790                     5.2                            0                                        0
  Qasim                              1,370,727    5/1,091                   8.0                            0.4                                      0.5
  Taif                               1,257,888    7/1,866                   14.8                           0.6                                      0.4
  Ahsa                               1,193,373    57/5,359                  44.9                           4.8                                      1.1
  Tabuk                              887,383      1/732                     8.2                            0.1                                      0.1
  Hail                               670,468      0/685                     10.2                           0                                        0
  Najran                             568,631      10/494                    8.7                            1.8                                      2.0
  Baha                               461,360      0/184                     4.0                            0                                        0
  Hafr al-Batin                      437,349      0/145                     3.3                            0                                        0
  Bisha                              379,521      0/227                     6.0                            0                                        0
  Northern Borders                   359,297      0/240                     6.7                            0                                        0
  Jauf                               329,277      0/390                     11.8                           0                                        0
  Qunfudha                           304,392      0/183                     6.0                            0                                        0
  Qurayat                            165,629      0/122                     7.4                            0                                        0
     Total                           30,770,375   384/56,472                18.4                           1.2                                      0.7
  Hajj pilgrims                                                                                                                                     
  Total                              1,952,817    0/888                     4.5                            0                                        0

\*Population data from ([@R10]).

In addition, surveillance during the annual Hajj pilgrimage included 888 tested persons during September 2015, representing 4.5 tested persons/10,000 among 1,952,817 pilgrims. None tested positive for MERS-CoV.

Among 8,032 children [\<]{.ul}14 years of age, 10 (0.1%) tested positive, including 5 who were \<1 year of age. At least 7 of the 10 children were tested because of exposure to a MERS case-patient. The number of tests among children [\<]{.ul}14 years of age temporarily dropped after the case definition revision in June 2015, which introduced more stringent criteria for testing.

Conclusions
===========

Surveillance and testing for MERS-CoV infection is extensive and widespread in Saudi Arabia. During our study, an average of \>5,000 persons per month were identified as being at high risk for infection due to clinical or epidemiologic criteria and were subsequently tested. MERS was first recognized in 2012, and as of November 3, 2016, Saudi Arabia has reported 80.9% of the cases reported worldwide ([@R11]); this distinction may be partly due to the country's robust implementation of surveillance practices and the ready availability of testing, which is facilitated by HESN. We found few other published descriptions of surveillance practices for MERS-CoV ([@R12],[@R13]).

Confirmed MERS case-patients represented \<1% of all tested persons in Saudi Arabia. Most tests were conducted for persons with community-acquired pneumonia, among whom the positivity rate was predictably low. Positivity rates were highest among persons tested because of presumed exposure to MERS case-patients (i.e., those tested because of healthcare-acquired pneumonia or onset of symptoms following contact with a confirmed case-patient).

Only 0.1% of children [\<]{.ul}14 years of age tested positive for MERS-CoV; this was the lowest rate among all age groups. Most MERS-CoV--positive children [\<]{.ul}14 years of age were tested because of high-risk exposures, not because they met clinical criteria. Although the proportion of positive tests was highest among persons [\>]{.ul}35 years of age, the number of tests was highest among persons 18--34 years of age, perhaps because of widespread testing of healthcare workers during outbreaks.

The largest number of tests was conducted in November, coinciding with the winter respiratory virus season. In comparison, the proportion of positive tests peaked in May and August, coinciding with outbreaks that occurred in Ahsa ([@R14]) and Riyadh ([@R15]), respectively.

Our analysis had limitations. Variations were probably present in the reporting practices of the various data reporters, in the clinical diagnostic practices used across Saudi Arabia, and among investigation teams. Such variations could affect the completeness, accuracy, and timeliness of the data used for this assessment.

Surveillance and testing for MERS-CoV throughout Saudi Arabia is extensive, as documented by HESN; in a single month during this study, \>9,000 patients at high risk for MERS were investigated. A continued robust approach to the early detection of patients with MERS is critical for the prompt implementation of infection-control precautions and the prevention of healthcare-associated transmission of MERS-CoV.

###### Technical Appendix

Definitions for suspected cases of Middle East respiratory syndrome coronavirus in Saudi Arabia.
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